301 related articles for article (PubMed ID: 25284586)
1. Myeloid zinc-finger 1 (MZF-1) suppresses prostate tumor growth through enforcing ferroportin-conducted iron egress.
Chen Y; Zhang Z; Yang K; Du J; Xu Y; Liu S
Oncogene; 2015 Jul; 34(29):3839-47. PubMed ID: 25284586
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress.
Jiang X; Zhang C; Qi S; Guo S; Chen Y; Du E; Zhang H; Wang X; Liu R; Qiao B; Yang K; Zhang Z; Xu Y
Oncotarget; 2016 Dec; 7(51):84893-84906. PubMed ID: 27768596
[TBL] [Abstract][Full Text] [Related]
3. Disordered signaling governing ferroportin transcription favors breast cancer growth.
Chen Y; Zhang S; Wang X; Guo W; Wang L; Zhang D; Yuan L; Zhang Z; Xu Y; Liu S
Cell Signal; 2015 Jan; 27(1):168-76. PubMed ID: 25451081
[TBL] [Abstract][Full Text] [Related]
4. Effects of Ferroportin-Mediated Iron Depletion in Cells Representative of Different Histological Subtypes of Prostate Cancer.
Deng Z; Manz DH; Torti SV; Torti FM
Antioxid Redox Signal; 2019 Mar; 30(8):1043-1061. PubMed ID: 29061069
[TBL] [Abstract][Full Text] [Related]
5. Nuclear transcription factor Nrf2 suppresses prostate cancer cells growth and migration through upregulating ferroportin.
Xue D; Zhou C; Shi Y; Lu H; Xu R; He X
Oncotarget; 2016 Nov; 7(48):78804-78812. PubMed ID: 27788496
[TBL] [Abstract][Full Text] [Related]
6. miR-20a regulates expression of the iron exporter ferroportin in lung cancer.
Babu KR; Muckenthaler MU
J Mol Med (Berl); 2016 Mar; 94(3):347-59. PubMed ID: 26560875
[TBL] [Abstract][Full Text] [Related]
7. miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2.
Chen X; Hao B; Han G; Liu Y; Dai D; Li Y; Wu X; Zhou X; Yue Z; Wang L; Cao Y; Liu J
J Cell Biochem; 2015 Feb; 116(2):225-32. PubMed ID: 25160587
[TBL] [Abstract][Full Text] [Related]
8. Estrogen contributes to regulating iron metabolism through governing ferroportin signaling via an estrogen response element.
Qian Y; Yin C; Chen Y; Zhang S; Jiang L; Wang F; Zhao M; Liu S
Cell Signal; 2015 May; 27(5):934-42. PubMed ID: 25660146
[TBL] [Abstract][Full Text] [Related]
9. MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6).
Liu D; Tao T; Xu B; Chen S; Liu C; Zhang L; Lu K; Huang Y; Jiang L; Zhang X; Huang X; Zhang L; Han C; Chen M
Biochem Biophys Res Commun; 2014 Feb; 445(1):151-6. PubMed ID: 24491557
[TBL] [Abstract][Full Text] [Related]
10. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
[TBL] [Abstract][Full Text] [Related]
11. miR-105 inhibits prostate tumour growth by suppressing CDK6 levels.
Honeywell DR; Cabrita MA; Zhao H; Dimitroulakos J; Addison CL
PLoS One; 2013; 8(8):e70515. PubMed ID: 23950948
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling.
Guan H; Liu C; Fang F; Huang Y; Tao T; Ling Z; You Z; Han X; Chen S; Xu B; Chen M
Oncotarget; 2017 Feb; 8(9):14693-14707. PubMed ID: 28107193
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
14. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.
Xing C; Ci X; Sun X; Fu X; Zhang Z; Dong EN; Hao ZZ; Dong JT
Neoplasia; 2014 Nov; 16(11):883-99. PubMed ID: 25425963
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-19a regulates proliferation and apoptosis of castration-resistant prostate cancer cells by targeting BTG1.
Lu K; Liu C; Tao T; Zhang X; Zhang L; Sun C; Wang Y; Chen S; Xu B; Chen M
FEBS Lett; 2015 Jun; 589(13):1485-90. PubMed ID: 25936765
[TBL] [Abstract][Full Text] [Related]
16. MiR-20b Down-Regulates Intestinal Ferroportin Expression In Vitro and In Vivo.
Jiang S; Fang X; Liu M; Ni Y; Ma W; Zhao R
Cells; 2019 Sep; 8(10):. PubMed ID: 31554201
[TBL] [Abstract][Full Text] [Related]
17. Cell-specific regulation of Ferroportin transcription following experimentally-induced acute anemia in mice.
Chiabrando D; Fiorito V; Marro S; Silengo L; Altruda F; Tolosano E
Blood Cells Mol Dis; 2013 Jan; 50(1):25-30. PubMed ID: 22921471
[TBL] [Abstract][Full Text] [Related]
18. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J
Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282
[TBL] [Abstract][Full Text] [Related]
19. miR-204 is dysregulated in metastatic prostate cancer in vitro.
Todorova K; Metodiev MV; Metodieva G; Zasheva D; Mincheff M; Hayrabedyan S
Mol Carcinog; 2016 Feb; 55(2):131-47. PubMed ID: 25630658
[TBL] [Abstract][Full Text] [Related]
20. An important role of the hepcidin-ferroportin signaling in affecting tumor growth and metastasis.
Guo W; Zhang S; Chen Y; Zhang D; Yuan L; Cong H; Liu S
Acta Biochim Biophys Sin (Shanghai); 2015 Sep; 47(9):703-15. PubMed ID: 26201356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]